Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hospira Inc Reaffirms FY 2013 Guidance


Wednesday, 31 Jul 2013 07:47am EDT 

Hospira Inc announced that announced that for fiscal 2013, it continues to project the year-over-year change to adjusted net sales to be negative 1% to positive 1%. On a GAAP basis, the year-over-year change to net sales is expected to range between negative 5% and negative 3%, Foreign exchange is now expected to detract from net sales by a negative 1%. The company continues to expect Adjusted diluted earnings per share (EPS) for fiscal 2013 is expected to be in a range of $2.00 to $2.10. The Company reported revenue of $4.092 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $4.063 billion and EPS of $2.03 for fiscal 2013. 

Company Quote

88.95
0.06 +0.07%
2 Jul 2015